The market has been down on Evogene Ltd (EVGN) stock recently. EVGN gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.
Evogene Ltd has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on EVGN!
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With EVGN Stock Today?
Evogene Ltd (EVGN) stock is trading at $1.45 as of 2:07 PM on Thursday, Jan 20, a gain of $0.06, or 4.32% from the previous closing price of $1.39. The stock has traded between $1.37 and $1.50 so far today. Volume today is below average. So far 213,252 shares have traded compared to average volume of 338,366 shares.
More About Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.
Click Here to get the full Stock Report for Evogene Ltd stock.